ClinicalTrials.gg
RecruitingNCT02025023CTSUpdated Feb 6, 2020

Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

A Phase 3 interventional study of 5-fluorouracil Injection and Triamcinolone Acetonide in Chalazion, sponsored by University of Washington. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-06.

Sponsored by University of Washington · Phase 3, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies testing Triamcinolone Acetonide in Pain — 4 open to participants now, 4 under way, 2 of them phase 3. Triamcinolone Acetonide · Pain.

Planned enrollment
7th of 17
120 · median 81
Started
2013
the only one that year
Phase 3
6 of 17
2 open now
Registered
2nd of 17
by date
Lead sponsor
1 of 17
University of Washington

Among the 17 studies testing Triamcinolone Acetonide in Pain, this one is the 7th largest by planned enrollment, is the only one that started in 2013, is one of 6 in phase 3, and was the 2nd registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

4 of the 17 studies testing Triamcinolone Acetonide in Pain are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

About Triamcinolone Acetonide

Triamcinolone Acetonide: first FDA approval 1958 (TRIAMCINOLONE ACETONIDE). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies testing Triamcinolone Acetonide in Pain, or all of them as a file.
02

Study summary

Local injection of 5-fluorouracil into a chalazion (stye) is as effective as local injection of triamcinolone (steroid) and incision and curettage for treatment of chalazia.

Read the detailed description

This is a prospective randomized interventional study comparing four current standard-of-care treatments for chalazia: incision and curettage, local injection of triamcinolone, local injection of 5-FU, and local injection of combination triamcinolone/5-FU.

03

Conditions studied

  • Chalazion

Browse trials for

Keywords

  • Size
  • Pain
  • Resolution
  • Complications
  • Swelling
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Single or multiple chalazia in a single eyelid

Exclusion criteria

Exclusion Criteria:

  • Chalazia present for less than one month and no previous injection or incision and curettage
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Incision and Curettage

    A vertical incision over the area of chalazion will be done. Inflammatory material will be removed and the chalazion capsule will be excised.

    Procedure: Incision and Curettage

  • Active comparator
    Injection of Triamcinolone Acetonide

    0.1 ml of triamcinolone is injected directly in the chalazion.

    Drug: Triamcinolone Acetonide · Procedure: Incision and Curettage

  • Active comparator
    Injection of 5-fluorouracil

    0.1 ml of 5-fluorouracil is injected directly in the lesion transconjunctivally.

    Drug: 5-fluorouracil Injection · Procedure: Incision and Curettage

  • Active comparator
    Injection of triamcinolone/5FU mixture

    0.1 ml of a 4:1 mixture of 4 parts 5-FU and 1 part triamcinolone is injected in the lesion.

    Procedure: Incision and Curettage · Drug: Triamcinolone Acetonide/5-fluorouracil mixture

Interventions

  • DrugFluorouracilStudies of FluorouracilFluorouracil pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    If the chalazion is present at follow-up visit, another injection of 5-FU will be given.

    Also known as: 5-FU

  • If chalazion present at follow-up, another Triamcinolone injection will be done.

    Also known as: triamcinolone

  • ProcedureIncision and Curettage

    If chalazion present at follow-up visit, patient will be randomized to receive local injection of either triamcinolone, 5-FU, or triamcinolone/5-FU mixture.

  • DrugTriamcinolone Acetonide/5-fluorouracil mixture

    If chalazion persists at follow-up visit, another injection of triamcinolone/5-FU mixture will be done.

06

What researchers measure

Primary outcomes

  1. Size of chalazion

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
  • University of Washington Eye Institute at Harborview
    Seattle, Washington 98104, United States
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2013, a primary completion of Jul 2025 and a completion of Jul 2026. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2013
First posted
Dec 31, 2013
Start
Dec 2013
Primary completionEst.
Jul 2025
CompletionEst.
Jul 2026
Last update
Feb 6, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02025023
Responsible party
Matthew Zhang (Assistant Professor of Ophthalmology, University of Washington) — Principal investigator
First posted
Dec 31, 2013
Start date
Dec 2013
Primary completion
Jul 2025 (estimated)
Completion
Jul 2026 (estimated)
Last update
Feb 6, 2020

Study contacts

Simona Vuletic
Contact
simona@uw.edu
206-520-9728
Ian Luttrell
Contact
lutri@uw.edu
206-520-8305
Matthew M Zhang, MD
principal investigator · University of Washington Eye Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Fluorouracil · Triamcinolone Acetonide

Start the discussion